Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma

Cancer

Volumn 83, Issue 11, 1998, Pages 2400-2407

  Fuchs, Jörg ^a   Wenderoth, Marc ^a   Von Schweinitz, Dietrich ^a   Haindl, Johann ^a   Leuschner, Ivo ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Chemotherapy; Hepatoblastoma; Immunodeficient mice; Xenograft

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; HEPATOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALPHA-FETOPROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CELL DIVISION; CHILD, PRESCHOOL; CISPLATIN; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; ETOPOSIDE; HEPATOBLASTOMA; HUMANS; IFOSFAMIDE; INFANT; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032402185     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981201)83:11<2400::AID-CNCR21>3.0.CO;2-6     Document Type: Article

References (29)

1. Dykes DJ, Abbott BJ, Mayo JG, Harrison SD Jr. Laster WR Jr. Simpson L, et al. Development of human tumor xenograft models for in vivo evaluation of new antitumor drugs. Contrib Oncol 1992;42:1-22.
2. Rousseau-Merk MF, Bigel P, Mouly H, Flammant F, Zucker JM, Wache AC, et al. Transplantability in nude mice of embryonic and other childhood tumours. Br J Cancer 1985;52:197-283.
3. Bannerman RM. Hematology. In: Forster H, Small J, Fox J, editors. The mouse in biomedical research. Volume 2. New York: Academic Press, 1983:294-308.
4. Giovanella BC, Fogh J. The nude mice in cancer research. Adv Cancer Res 1995;44:69-120.
5. Bouma ME, Rogier E, Verthier N, Labarre C, Feldmann G. Further cellular investigation of human hepatoblastoma-derived cell line HepG2: morphology and immunocytochemical studies of hepatic secreted proteins. In vitro Cell Dev Biol 1989;25:267-75.
6. Dot I. Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Gann 1976;67:1-10.
7. Von Schweinitz D, Hadam MR, Welte K, Mildenberger H, Pietsch T. Production of interleukin-1 and interleukin-6 in hepatoblastoma. Int J Cancer 1993;53:728-34.
8. Von Schweinitz D, Bürger D, Weinel P, Ertmann R, Hecker H, Mildenberger H. The treatment of malignant liver tumours in childhood. An interim report of the multicentric study HB-89 of the GPOH. Klin Pädiatr 1992;204:214-20.
9. Harstick A, Schmoll HJ, Casper J, Wilke HJ, Polowida H. Activity of cytostatic drugs in two heterotransplanted human testicular cancer cell lines with different sensitivity to standard agents. Eur J Cancer 1990;26:898-901.
10. Budach V, Budach W, Schmauder B, Stuschke M, Scheuten M. Response rates of human soft-tissue sarcoma xenografts to single doses of adriamycin, ifosfamide, dacarbazine and cisplatin. Contrib Oncol 1992;42:483-4.
11. Hainsworth JD, Greco FA. Etoposide-Twenty years later Ann Oncol 1995;6:325-41.
12. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1966;50:219-44.
13. Fuchs J, Schmidt D, Pietsch T, Miller K, von Schweinitz D. Successful transplantation of human hepatoblastoma into immunodeficient mice. J Pediatr Surg 1996;31:1241-6.
14. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons, 1980.
15. Freshney RJ. Culture of animal cells-a manual of basic techniques. New York: Wiley-Liss, Inc., 1994.
16. Wynford-Thomas D, Williams ED. Use of bromdeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet 1986;19:183-94.
17. Ishak KG, Glunz PR. Hepatoblastoma and hepatocarcinoma in infancy and childhood. A report of 47 cases. Cancer 1967; 20:396-422.
18. King DR, Ortega J, Campbell J, Haas J, Ablin A, Lloyd D, et al. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg 1991;26:1074-81.
19. Reynolds M, Douglass EC, Finegold M, Cantor A, Glicksman A, et al. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992;27:1080-4.
20. von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Bürger D, et al. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma. A report from the German Cooperative Liver Tumor Study HB - 89. J Pediatr Surg 1995;30:845-52.
21. Beck WT. The cell biology of multiple drug resistance. Biochem Pharmacol 1987;36:2879-87.
22. Köpf-Maier P. Tumor - host interaction following heterotransplantation of human tumors into athymic mice: a morphological study. Contrib Oncol 1992;42:152-68.
23. Neely JE, Ballard ET, Britt AL, Workmann L. Characteristics of 85 pediatric tumors heterotransplantated into nude mice. Exp Cell Biol 1983;51:217-27.
24. Von Schweinitz D, Schmidt D, Fuchs J, Weite K, Pietsch T. Extramedullary hematopoieises and intratumoral production of cytokines in childhood hepatoblastoma. Pediatr Res 1995;38:555-63.
25. Hata Y, Takada N, Sasaki F, Abe T, Hamada H, Takahahi H, et al. Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents. J Pediatr Surg 1992;27:724-27.
26. Saxena R, Leake JL, Shafford EA, Davenport M, Mowat AP, Pritchard J, et al. Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg Pathol 1993;17:1266-71.
27. Loockwood L, Henly D, Giles GR, Lawis IJ, Bailey CC. Cisplatin-resistent metastatic hepatoblastoma: complete response to carboplatin, etoposide, and liver transplatation. Med Pediatr Oncol 1993;21:517-20.
28. Abenoza P, Manivel CJ, Wick R, Hagen K, Dehner LP. Hepatoblastoma. An immuno-histochemical and ultrastructural study. Hum Pathol 1986;18:1025-35.
29. Pietsch T, Fonatsch CH, Albrecht S, Maschek HJ, v. Schweinitz D. Characterization of the continuous cell line HepT1 derived from human hepatoblastoma. Lab Invest 1996;74: 809-17.